basiliximab

The drug is used for the prevention of acute kidney rejection during kidney transplantation in adults and children aged 1 to 17 years.

Form: powder for solution for injection/infusion

ATC: L04AC02

Manufacturer: Novartis Pharma GmbH (release of the finished medicinal product)/Novartis Pharmaceuticals, S.A. (release of the finished medicinal product)